FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384070970> ?p ?o ?g. }

• W4384070970 abstract "Abstract Background Interleukin-5 (IL-5) has recently been shown to play a crucial role in eosinophil-mediated diseases, implying that an IL-5 receptor alpha chain (IL-5Rα) antibody (benralizumab) can be effective against eosinophilic esophagitis (EoE). Here, we present a case in which benralizumab significantly improved the symptoms and signs of an elderly Asian woman with EoE who had become resistant to existing treatments. Case presentation: A 73-year-old woman with an 8-year history of asthma and a 7-year history of dysphagia presented to our hospital with worsening dysphagia and other digestive symptoms. Blood biochemical findings revealed an increase in the eosinophil fraction of white blood cells (42.2%), and a conventional chest computed tomography scan revealed esophageal wall thickening. An upper gastrointestinal endoscopy revealed mucosal edema as well as multiple esophageal rings, and esophageal biopsy specimens showed an eosinophilic infiltrate of more than 15 cells/ high power field (HPF). Based on these findings, she was diagnosed as EoE complicated by severe asthma. We firstly administrated 20 mg/day of prednisolone, rabeprazole sodium and budesonide oral therapy; however, they were ineffective and her dysphagia worsened over time. Then, benralizumab treatment in combination with these drugs was started. Her dysphagia completely disappeared 2 weeks after starting benralizumab, and an upper endoscopy showed that the clinical findings had completely disappeared. Benralizumab was then given to her for 41 months, and her symptoms remained in remission. In addition, she had no EoE recurrence for more than 6 months after discontinuing benralizumab. Conclusions Benralizumab in combination with other multiple drugs significantly improved the symptoms and examination findings of an elderly patients with EoE. Furthermore, she experienced no recurrence even after discontinuing benralizumab withdrawal, suggesting that benralizumab is an appropriate therapeutic option for EoE." @default.
• W4384070970 created "2023-07-13" @default.
• W4384070970 creator A5000796870 @default.
• W4384070970 creator A5009220795 @default.
• W4384070970 creator A5010056452 @default.
• W4384070970 creator A5016828120 @default.
• W4384070970 creator A5022073552 @default.
• W4384070970 creator A5043856670 @default.
• W4384070970 creator A5065052012 @default.
• W4384070970 creator A5070426550 @default.
• W4384070970 creator A5083118595 @default.
• W4384070970 creator A5083392160 @default.
• W4384070970 date "2023-07-12" @default.
• W4384070970 modified "2023-09-25" @default.
• W4384070970 title "Benralizumab treatment resulted in remission of conventional therapy-resistant eosinophilic esophagitis: a case report" @default.
• W4384070970 cites W1981756521 @default.
• W4384070970 cites W2004689414 @default.
• W4384070970 cites W2033559734 @default.
• W4384070970 cites W2075782740 @default.
• W4384070970 cites W2086384139 @default.
• W4384070970 cites W2087770516 @default.
• W4384070970 cites W2098392838 @default.
• W4384070970 cites W2112520921 @default.
• W4384070970 cites W2123896274 @default.
• W4384070970 cites W2157860317 @default.
• W4384070970 cites W2239714890 @default.
• W4384070970 cites W2741654639 @default.
• W4384070970 cites W2742468996 @default.
• W4384070970 cites W2769652538 @default.
• W4384070970 cites W2799383149 @default.
• W4384070970 cites W2809988035 @default.
• W4384070970 cites W2996976309 @default.
• W4384070970 cites W3009099684 @default.
• W4384070970 cites W3201668017 @default.
• W4384070970 cites W3205584737 @default.
• W4384070970 cites W4210630219 @default.
• W4384070970 cites W4226529922 @default.
• W4384070970 cites W4229038420 @default.
• W4384070970 cites W4304690949 @default.
• W4384070970 cites W4312140778 @default.
• W4384070970 cites W4313237193 @default.
• W4384070970 doi "https://doi.org/10.21203/rs.3.rs-3098414/v1" @default.
• W4384070970 hasPublicationYear "2023" @default.
• W4384070970 type Work @default.
• W4384070970 citedByCount "0" @default.
• W4384070970 crossrefType "posted-content" @default.
• W4384070970 hasAuthorship W4384070970A5000796870 @default.
• W4384070970 hasAuthorship W4384070970A5009220795 @default.
• W4384070970 hasAuthorship W4384070970A5010056452 @default.
• W4384070970 hasAuthorship W4384070970A5016828120 @default.
• W4384070970 hasAuthorship W4384070970A5022073552 @default.
• W4384070970 hasAuthorship W4384070970A5043856670 @default.
• W4384070970 hasAuthorship W4384070970A5065052012 @default.
• W4384070970 hasAuthorship W4384070970A5070426550 @default.
• W4384070970 hasAuthorship W4384070970A5083118595 @default.
• W4384070970 hasAuthorship W4384070970A5083392160 @default.
• W4384070970 hasBestOaLocation W43840709701 @default.
• W4384070970 hasConcept C126322002 @default.
• W4384070970 hasConcept C141071460 @default.
• W4384070970 hasConcept C191897082 @default.
• W4384070970 hasConcept C192562407 @default.
• W4384070970 hasConcept C2776042228 @default.
• W4384070970 hasConcept C2777037409 @default.
• W4384070970 hasConcept C2777832160 @default.
• W4384070970 hasConcept C2778456384 @default.
• W4384070970 hasConcept C2778527123 @default.
• W4384070970 hasConcept C2779134260 @default.
• W4384070970 hasConcept C2779185760 @default.
• W4384070970 hasConcept C2780596822 @default.
• W4384070970 hasConcept C2781065132 @default.
• W4384070970 hasConcept C71924100 @default.
• W4384070970 hasConcept C90924648 @default.
• W4384070970 hasConceptScore W4384070970C126322002 @default.
• W4384070970 hasConceptScore W4384070970C141071460 @default.
• W4384070970 hasConceptScore W4384070970C191897082 @default.
• W4384070970 hasConceptScore W4384070970C192562407 @default.
• W4384070970 hasConceptScore W4384070970C2776042228 @default.
• W4384070970 hasConceptScore W4384070970C2777037409 @default.
• W4384070970 hasConceptScore W4384070970C2777832160 @default.
• W4384070970 hasConceptScore W4384070970C2778456384 @default.
• W4384070970 hasConceptScore W4384070970C2778527123 @default.
• W4384070970 hasConceptScore W4384070970C2779134260 @default.
• W4384070970 hasConceptScore W4384070970C2779185760 @default.
• W4384070970 hasConceptScore W4384070970C2780596822 @default.
• W4384070970 hasConceptScore W4384070970C2781065132 @default.
• W4384070970 hasConceptScore W4384070970C71924100 @default.
• W4384070970 hasConceptScore W4384070970C90924648 @default.
• W4384070970 hasLocation W43840709701 @default.
• W4384070970 hasOpenAccess W4384070970 @default.
• W4384070970 hasPrimaryLocation W43840709701 @default.
• W4384070970 hasRelatedWork W2038449916 @default.
• W4384070970 hasRelatedWork W2123896274 @default.
• W4384070970 hasRelatedWork W2339552918 @default.
• W4384070970 hasRelatedWork W2591530977 @default.
• W4384070970 hasRelatedWork W2950649688 @default.
• W4384070970 hasRelatedWork W2978515299 @default.
• W4384070970 hasRelatedWork W4229038420 @default.
• W4384070970 hasRelatedWork W4283206684 @default.
• W4384070970 hasRelatedWork W4321851479 @default.
• W4384070970 hasRelatedWork W4376226613 @default.

• next